Incidence of brimonidine allergy in patients previously allergic to apraclonidine

Journal of Glaucoma

Volumn 9, Issue 3, 2000, Pages 235-238

  Williams, G C ^a   Orengo Nania, S ^a   Gross, R L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Allergy; Brimonidine; Glaucoma

Indexed keywords

APRACLONIDINE; BRIMONIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; CROSS REACTION; DERMATITIS; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; HYPEREMIA; INCIDENCE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 0034442950     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200006000-00006     Document Type: Article

References (18)

1. Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans
2. The global impact of glaucoma
3. Ophthalmological studies with dichlorophenylaminoimidazoline
4. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists
5. Studies of p-aminoclonidine as a potential antiglaucoma agent
6. New medical treatments for glaucoma
7. Effects of apraclonidine on aqueous humor dynamics in human eyes
8. Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions
9. Comparison of apraclonidine and timolol in chronic open-angle glaucoma
10. Clinical experience with apraclonidine 0.5%
11. Short-term effects of unilateral 1% apraclonidine therapy
12. 2-adrenoreceptor agonists in glaucoma
13. Effects of brimonidine on aqueous humor dynamics in human eyes
14. A proposed mechanism for p-aminoclonidine allergenicity based on its relative oxidative lability
15. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension
16. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension
17. Lack of cross-reactive allergic response to brimonidine in patients with known apraclonidine allergy